The recent landscape of metabolic health in the UK is seeing increasing interest in the pairing of high-dose NAD+ supplementation – often at 1g dosage – and the novel GLP-1 receptor agonist Retatrutide (or https://retatrutide-20mg576366.wikififfi.com/user